Cryoablation of AVNRT when sustained tachycardia cannot be induced
Patcharapong Suntharos1, Andrew D Blaufox
1Division of Pediatric Cardiology, The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York 11040, USA. PSunthar@NSHS.edu
Background:
Inducibility of sustained tachycardia is preferred prior to cryoablation for atrioventricular nodal reentrant tachycardia (AVNRT).
Method:
The Pediatric Electrophysiology Database of a single institution was retrospectively reviewed for patients with clinical sustained (≥ 30 seconds of symptoms) AVNRT documented by noninvasive means who underwent cryoablation for AVNRT to determine if intermediate-term success with cryoablation for AVNRT can be achieved without inducibility of sustained AVNRT during electrophysiology study (EPS).
Results:
There were no differences between patients with sustained (≥ 30 seconds of tachycardia) AVNRT (N = 67) and patients with nonsustained (ns, ≥ 3 beats and <30 seconds of tachycardia) AVNRT at EPS (N = 16). Acute success was achieved without PR prolongation in all patients. Although duration of follow-up was shorter for the sustained group than the nonsustained group (2.7 ± 1.6 years vs 3.8 ± 1.4 years, P = 0.008), recurrence rate was similar (6% vs 6.3%, P = 0.6). In patients with only nonsustained AVNRT at EPS, supportive findings for procedural effectiveness seen: (1) Dual atrioventricular node physiology (DAVNP) was eliminated in 14/14, (2) the fast pathway effective refractory period (FPERP) decreased after ablation in 10/11, (3) sustained slow pathway conduction was eliminated in 8/8 including both patients without discrete DAVNP prior to ablation, and (4) FPERP increased during lesion formation in 10/10.
Conclusion:
Intermediate-term success can be achieved with cryoablation of ns AVNRT. Attention should be paid to supportive indicators of damage to slow pathway.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use


